Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic

Evaluation of Strategies for the Assessment of Drug-Drug Interactions Involving Cytochrome P450 Enzymes. European Journal of Drug Metabolism and Pharmacokinetics 43(6): 737-750, 2018

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: Prediction of in vivo drug-drug interactions. European Journal of Clinical Pharmacology 55(11-12): 843-852, 2000

Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review). International Journal of Molecular Medicine 3(3): 227-238, 1999

Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists. Journal of Pharmacology and Experimental Therapeutics 316(3): 1187-1194, 2005

Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 Enzymes. Journal of Psychiatric Practice 26(2): 126-134, 2020

Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Brain Research 1045(1-2): 142-149, 2005

Supplement 9: Toxicological Evaluation of Chemical Interactions || Interactions of Ingested Food/Beverage, and Tobacco Components Involving Human Cytochrome P4501A2, 2A6, 2E1, and 3A4 Enzymes. Environmental Health Perspectives 102: 49-53, 1994

Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes. Journal of Thrombosis and Haemostasis 8(12): 2708-2717, 2010

Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 37(2): 139-154, 2007

Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy. Plos one 8(12): E82562, 2013

Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450. Expert Opinion on Drug Metabolism and Toxicology 7(11): 1411-1429, 2011

Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicological Reviews 23(4): 239-249, 2004

Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda. Journal of Antimicrobial ChemoTherapy 70(12): 3317-3322, 2015

Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). British Journal of Clinical Pharmacology 76(4): 587-602, 2013

In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions. Pharmacological Reports 2020, 2020